GB Sciences, Inc. Provides Update on Nevada State Licensing Applications

LAS VEGAS, Aug. 15, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (OTCQB:GBLX) a medical marijuana research and development company, announced they have completed and officially submitted 4 Nevada State license applications for 1 cultivation facility and 3 dispensaries as of August 13, 2014. The Company has already received a special use permit for a dispensary and cultivation facility in Clark County, Nevada. The special use permits issued by the County Commissioner's Office is expected to have some influence on the final State decision but does not guarantee State approval.

Image of the applications after being delivered to the State Office. Each full box contains one application.

A photo accompanying this release is available at

The Company submitted the applications early, days ahead of the deadline, heeding the advice of the State Office to ensure a quicker review as the State expects a rush of last minute applicants. The Company is confident in the thoroughness and accuracy of their applications and looks forward to receiving a prompt response from the State. The Company may receive an answer on their applications as early as this month but no later than November 3, 2014. Upon final State approval, The Company will receive business licenses to begin operations of their dispensaries and cultivation facility in Nevada.

CEO Craig Ellins said, "The State application process is an extremely difficult and lengthy one. Each application is hundreds of pages long and requires many supporting documents. Our team has put in countless hours ensuring each of the four application is fully completed and answered properly to satisfy the State Office."

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

The photo is also available at Newscom,, and via AP PhotoExpress.

CONTACT: Jonathan Barkman Riverview Capital Enterprises +1-866-845-0105Source:GrowBlox Sciences Inc